News

Customer satisfaction is a core value at NRG, and therefore we are very proud to be nominated for a Customer Experience Award in the category Biggest Riser by Integron, a large research company in Rotterdam.

The construction of the FIELD-LAB building on the Energy & Health Campus in Petten is ready to start. The necessary licenses, being the nuclear energy act permit by the Authority for Nuclear Safety and Radiation Protection (ANVS) and the building license by the council of Petten, have been acquired.

In the University of Warwick and King’s College London, the FIELD-LAB of NRG has found its first international partners. The universities will be involved in a project on cisplatin to improve existing treatment and to find out why it might not be as effective in all patients. By joining FIELD-LAB, the universities hope to accelerate the process. “The beauty of FIELD-LAB lies in providing a form of open European collaboration, by offering all partners valuable information and knowledge” says Dr Imberti, University of Warwick.

Medical isotope offers great perspective for the effective treatment of various cancer indications with limited side effects

Thanks to intensive collaboration between Curium and NRG, a complex project has been brought to a successful conclusion: the development and installation of a production process for the medical isotope Xenon-133.

Every day, 30.000 patients benefit from medical isotopes from Petten. The NRG reactor, where the medical isotopes are irradiated, changed its fuel to low-enriched uranium in 2006.

The official launch of FIELD-LAB took place on February 6, 2019 in Petten. A unique collaboration to benefit a wide range of patients.